Carsten Terjung
Wuppertal, NW 42113, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic Balance.
Journal: Journal of medicinal chemistry
Published: October 28, 2024
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: June 23, 2023
Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model.
Journal: Translational vision science & technology
Published: October 25, 2022
Emodepside targets SLO-1 channels of Onchocerca ochengi and induces broad anthelmintic effects in a bovine model of onchocerciasis.
Journal: PLoS pathogens
Published: January 05, 2021
Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).
Journal: Journal of medicinal chemistry
Published: September 24, 2020
Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury.
Journal: Free radical biology & medicine
Published: September 30, 2019
Antibody-Drug Conjugates with Pyrrole-Based KSP Inhibitors as the Payload Class.
Journal: Angewandte Chemie (International ed. in English)
Published: July 03, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026